Getagraph.com logo
S&P 500
(1.02%) 5 099.96 points
Dow Jones
(0.40%) 38 240 points
Nasdaq
(2.03%) 15 928 points
Oil
(-0.23%) $83.66
Gas
(-1.16%) $1.619
Gold
(0.10%) $2 349.60
Silver
(-0.07%) $27.52
Platinum
(0.25%) $924.40
USD/EUR
(0.40%) $0.935
USD/NOK
(0.62%) $11.02
USD/GBP
(0.19%) $0.801
USD/RUB
(0.00%) $92.17

Realaus laiko atnaujinimai Eris Lifesciences Limited [ERIS.NS]

Birža: NSE Sektorius: Healthcare Pramonė: Drug Manufacturers—Specialty & Generic
Atnaujinta26 bal. 2024 @ 12:59
25% discount on Stockinvest.us - Use code: Podcast

1.06% INR 892.95

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 12:59):

Eris Lifesciences Limited manufactures, markets, and distributes pharmaceutical products in India. It offers various branded formulations in various therapeutic areas, such as cardiovascular, anti–diabetes, anti-infective, antipyretics, vitamins/nutrients, gastroenterology, respiratory, gynecology, pediatrics, neurology, psychiatry, and pain/analgesics, as well as in-vitro fertilization, cosmetology, and dermatology...

Stats
Šios dienos apimtis 58 756.00
Vidutinė apimtis 230 030
Rinkos kapitalizacija 121.48B
EPS INR0 ( 2024-02-13 )
Kita pelno data ( INR0 ) 2024-05-14
Last Dividend INR7.35 ( 2022-08-11 )
Next Dividend INR0 ( N/A )
P/E 31.44
ATR14 INR0.844 (0.09%)

Tūris Koreliacija

Ilgas: -0.11 (neutral)
Trumpas: 0.12 (neutral)
Signal:(49.564) Neutral

Eris Lifesciences Limited Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
NECCLTD.NS0.892
BINDALAGRO.NS0.889
ROSSARI.NS0.887
SETFNIF50.NS0.882
AXISNIFTY.NS0.881
INDIANHUME.NS0.881
KOTAKNIFTY.NS0.88
ICICINIFTY.NS0.879
LICNFNHGP.NS0.879
BSLNIFTY.NS0.878
10 Labiausiai neigiamai susiję koreliacijos
SOMATEX.NS-0.88
JSL.NS-0.873
4THDIM.NS-0.859
KARDA.NS-0.839
BSELINFRA.NS-0.83
ISMTLTD.NS-0.819
GAIL.NS-0.817
KIRLFER.NS-0.815
FOSECOIND.NS-0.809
TARMAT.NS-0.804

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Eris Lifesciences Limited Koreliacija - Valiuta/Žaliavos

The country flag 0.00
( neutral )
The country flag -0.09
( neutral )
The country flag 0.00
( neutral )
The country flag 0.10
( neutral )
The country flag -0.07
( neutral )
The country flag 0.15
( neutral )

Eris Lifesciences Limited Finansinės ataskaitos

Annual 2022
Pajamos: INR16.62B
Bruto pelnas: INR13.09B (78.80 %)
EPS: INR28.10
FY 2022
Pajamos: INR16.62B
Bruto pelnas: INR13.09B (78.80 %)
EPS: INR28.10
FY 2022
Pajamos: INR13.26B
Bruto pelnas: INR10.65B (80.33 %)
EPS: INR29.89
FY 2021
Pajamos: INR11.93B
Bruto pelnas: INR9.51B (79.72 %)
EPS: INR26.16

Financial Reports:

No articles found.

Eris Lifesciences Limited Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
INR7.35
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A)

Eris Lifesciences Limited Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 3.44 - low (14.40%) | Divividend Growth Potential Score: 5.04 - Potential for dividend initiation, but uncertain (0.70%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend INR2.87 2020-03-19
Last Dividend INR7.35 2022-08-11
Next Dividend INR0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 4 --
Total Paid Out INR21.73 --
Avg. Dividend % Per Year 0.44% --
Score 1.99 --
Div. Sustainability Score 3.44
Div.Growth Potential Score 5.04
Div. Directional Score 4.24 --
Next Divdend (Est)
 (2024-10-30)
INR0 Estimate 0.00 %
Dividend Stability
0.06 Very Bad
Dividend Score
1.99
Pay Frequency
Annually
Yearly Payout
Year Amount Yield
2020 INR8.37 1.69%
2021 INR6.01 1.02%
2022 INR7.35 0.96%
2023 INR0 0.00%
2024 INR0 0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
SILINV.NS Dividend Junior 2023-08-18 Annually 23 0.63%
MBAPL.NS Dividend Junior 2023-09-18 Annually 8 0.44%
GUJAPOLLO.NS Ex Dividend Junior 2023-09-22 Annually 18 0.48%
BAYERCROP.NS Dividend Junior 2023-08-03 Annually 15 1.25%
PREMIERPOL.NS Dividend Junior 2023-09-11 Sporadic 9 0.39%
KAMDHENU.NS Dividend Junior 2023-08-14 Sporadic 17 0.32%
EDELWEISS.NS Dividend Junior 2023-09-18 Annually 17 2.38%
ADSL.NS Dividend Junior 2023-08-10 Sporadic 16 0.91%
STERTOOLS.NS Dividend Junior 2023-09-11 Annually 19 0.38%
NAHARCAP.NS No Dividend Player 2023-09-08 Annually 17 0.70%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.2101.5005.808.70[0 - 0.5]
returnOnAssetsTTM01.20000[0 - 0.3]
returnOnEquityTTM0.1671.5009.2610.00[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM00.800-5.00-4.00[1 - 3]
quickRatioTTM00.800-4.71-3.76[0.8 - 2.5]
cashRatioTTM01.500-1.111-1.667[0.2 - 2]
debtRatioTTM0-1.50000[0 - 0.6]
interestCoverageTTM8.081.0008.128.12[3 - 30]
operatingCashFlowPerShareTTM19.152.003.627.23[0 - 30]
freeCashFlowPerShareTTM19.152.000.4240.847[0 - 20]
debtEquityRatioTTM0-1.50000[0 - 2.5]
grossProfitMarginTTM0.8181.00010.0010.00[0.2 - 0.8]
operatingProfitMarginTTM0.2661.0006.676.67[0.1 - 0.6]
cashFlowToDebtRatioTTM01.000-1.111-1.111[0.2 - 2]
assetTurnoverTTM00.800-3.33-2.67[0.5 - 2]
Total Score3.44

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM31.431.0006.930[1 - 100]
returnOnEquityTTM0.1672.509.5210.00[0.1 - 1.5]
freeCashFlowPerShareTTM19.152.003.620.847[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM19.152.003.627.23[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM2.201.50010.000[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1421.0008.960[0.1 - 0.5]
Total Score5.04

Eris Lifesciences Limited

Eris Lifesciences Limited manufactures, markets, and distributes pharmaceutical products in India. It offers various branded formulations in various therapeutic areas, such as cardiovascular, anti–diabetes, anti-infective, antipyretics, vitamins/nutrients, gastroenterology, respiratory, gynecology, pediatrics, neurology, psychiatry, and pain/analgesics, as well as in-vitro fertilization, cosmetology, and dermatology. Eris Lifesciences Limited was incorporated in 2007 and is based in Ahmedabad, India.

Apie Signalai gyvai

Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.

Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.